I Boland

665 total citations
15 papers, 533 citations indexed

About

I Boland is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, I Boland has authored 15 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Neurology. Recurrent topics in I Boland's work include Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (5 papers) and Neuroblastoma Research and Treatments (4 papers). I Boland is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (5 papers) and Neuroblastoma Research and Treatments (4 papers). I Boland collaborates with scholars based in France and Canada. I Boland's co-authors include Gilles Vassal, Alain Gouyette, Jackie Morizet, Dominique Challine, Olivier Hartmann, Alain Deroussent, Dominique Valteau‐Couanet, Serge Koscielny, C Kalifa and Jean Bénard and has published in prestigious journals such as Blood, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

I Boland

14 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Boland France 11 207 153 146 140 102 15 533
Eveline de Bont Netherlands 8 133 0.6× 227 1.5× 45 0.3× 77 0.6× 113 1.1× 11 568
P. C. Hoffman United States 7 235 1.1× 209 1.4× 34 0.2× 161 1.1× 34 0.3× 16 488
P R Taylor United Kingdom 11 158 0.8× 323 2.1× 19 0.1× 137 1.0× 38 0.4× 20 517
Sabine Plasschaert Netherlands 9 181 0.9× 52 0.3× 27 0.2× 207 1.5× 116 1.1× 25 431
C. H. Van Zantwijk Netherlands 13 258 1.2× 257 1.7× 40 0.3× 116 0.8× 194 1.9× 19 672
Juan Eduardo Megías‐Vericat Spain 16 230 1.1× 359 2.3× 23 0.2× 164 1.2× 49 0.5× 57 654
Chabner Ba United States 10 132 0.6× 48 0.3× 52 0.4× 238 1.7× 19 0.2× 21 483
Cecilia Fu United States 16 404 2.0× 190 1.2× 21 0.1× 219 1.6× 340 3.3× 32 945
Shirley Kow Yin Kham Singapore 15 194 0.9× 205 1.3× 22 0.2× 84 0.6× 247 2.4× 33 669
J. Timothy Caldwell United States 13 376 1.8× 251 1.6× 22 0.2× 114 0.8× 15 0.1× 18 578

Countries citing papers authored by I Boland

Since Specialization
Citations

This map shows the geographic impact of I Boland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Boland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Boland more than expected).

Fields of papers citing papers by I Boland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Boland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Boland. The network helps show where I Boland may publish in the future.

Co-authorship network of co-authors of I Boland

This figure shows the co-authorship network connecting the top 25 collaborators of I Boland. A scholar is included among the top collaborators of I Boland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Boland. I Boland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Potter, Beth K., Holly Etchegary, Heather Howley, et al.. (2008). Exploring informed choice in the context of prenatal testing: findings from a qualitative study. Health Expectations. 11(4). 355–365. 47 indexed citations
2.
Wilson, Keith G., Jennifer Clinch, Dean Fergusson, et al.. (2006). Identification of Domains Relevant to Health-related Quality of Life in Patients Undergoing Major Surgery. Quality of Life Research. 15(5). 841–854. 8 indexed citations
3.
Bouligand, Jérôme, I Boland, D Valteau-Couanet, et al.. (2003). In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa). Bone Marrow Transplantation. 32(10). 979–986. 38 indexed citations
4.
Boland, I, Gilles Vassal, Jackie Morizet, et al.. (1999). Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations. British Journal of Cancer. 79(5-6). 787–792. 12 indexed citations
5.
Vassal, Gilles, Corinne Pondarré, I Boland, et al.. (1998). Preclinical development of camptothecin derivatives and clinical trials in pediatric oncology. Biochimie. 80(3). 271–280. 31 indexed citations
6.
Vassal, Gilles, I Boland, Amanda J. Watson, et al.. (1998). Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.. PubMed. 4(2). 463–8. 19 indexed citations
7.
Vassal, Gilles, I Boland, Alexandre Santos, et al.. (1997). Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice. International Journal of Cancer. 73(1). 156–163. 45 indexed citations
8.
Vassal, Gilles, Corinne Pondarré, Carlo Cappelli, et al.. (1997). DNA-Topoisomerase I, a new target for the treatment of neuroblastoma. European Journal of Cancer. 33(12). 2011–2015. 40 indexed citations
9.
Vassal, Gilles, I Boland, Alexandre Santos, et al.. (1997). Potent therapeutic activity of irinotecan (CPT‐11) and its schedule dependency in medulloblastoma xenografts in nude mice. International Journal of Cancer. 73(1). 156–163. 1 indexed citations
10.
Vassal, Gilles, Jean Bénard, Jackie Morizet, et al.. (1996). Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts. British Journal of Cancer. 74(4). 537–545. 89 indexed citations
11.
Vassal, Gilles, Serge Koscielny, Dominique Challine, et al.. (1995). Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation. Cancer Chemotherapy and Pharmacology. 37(3). 247–253. 83 indexed citations
12.
Vassal, Gilles, I Boland, Alain Deroussent, Dominique Georgin, & Alain Gouyette. (1993). Busulfan metabolism in cytosolic and microsomal mouse liver preparations. 34. 268. 1 indexed citations
13.
Fischer, Alain, Dominique Challine, I Boland, et al.. (1993). Busulfan disposition below the age of three: alteration in children with lysosomal storage disease. Blood. 82(3). 1030–1034.
14.
Challine, Dominique, Serge Koscielny, O Hartmann, et al.. (1993). Chronopharmacology of high-dose busulfan in children.. PubMed. 53(7). 1534–7. 45 indexed citations
15.
Vassal, Gilles, Alain Fischer, Dominique Challine, et al.. (1993). Busulfan disposition below the age of three: alteration in children with lysosomal storage disease. Blood. 82(3). 1030–1034. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026